CIK: 0001634557
申报总市值
—
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | 股票-医疗保健 | 33.86% | — | +1.84% | |
| 2 | PRTA | Prothena Corporation plc | 股票-其他 | 24.42% | — | +0.09% | |
| 3 | ALKS | Alkermes plc | 股票-医疗保健 | 19.94% | — | -1.30% | |
| 4 | TBPH | Theravance Biopharma, Inc. | 股票-其他 | 16.13% | -71.30% | EXIT | |
| 5 | BIIB | Biogen INC | 股票-医疗保健 | 3.13% | — | +45.83% | |
| 6 | GILD | Gilead Sciences INC | 股票-医疗保健 | 2.12% | — | +26.19% | |
| 7 | NWBO | Northwest Biotherapeutics | 股票-其他 | 0.42% | — | -4.25% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | +5.7% | +1.84% | 加仓 |
| 2 | ALKS | Alkermes plc | +5.6% | -1.30% | 减仓 |
| 3 | TBPH | Theravance Biopharma, Inc. | +2.4% | +11.70% | 加仓 |
| 4 | BIIB | Biogen INC | +1% | +45.83% | 加仓 |
| 5 | GILD | Gilead Sciences INC | +0.6% | +26.19% | 加仓 |
| 6 | NWBO | Northwest Biotherapeutics | -0.2% | -4.25% | 减仓 |
| 7 | PRTA | Prothena Corporation plc | -0.5% | +0.09% | 加仓 |
| 8 | REYN | Reynolds Consumer Products Inc. | — | EXIT | 清仓 |